There are currently no press releases for this ticker. Please check back later.
ViroMed Company Ltd., develops biopharmaceutical products using recombinant DNA and other technologies. The Company is developing therapeutics in the areas of cardiovascular disease, cancer, and immune disorder.
599 Gwanak-ro 5th Floor, Building 203 Gwanak Seoul, 151-747 Korea, Republic of (South)